Veracyte, Inc. Share Price
NASDAQ: VCYT | Mid CapVeracyte, Inc. Stock Performance
Veracyte, Inc. Share Price Today
As of 8 October 2026, Veracyte, Inc.'s share price is $43.17. The stock opened at $43.67, compared to its previous close of $44.63. During today's trading session, Veracyte, Inc.'s share price traded between $42.40 and $43.97, with an average price of $43.19. Over the past 52 weeks, the stock has recorded a high of $60.77 and a low of $29.45. In terms of performance, Veracyte, Inc.'s share price has risen by 31.12% over the last six months and is up 18.89% on a year-on-year basis.
Veracyte, Inc. Share Price Chart
Veracyte, Inc. Quarterly Profit & Loss
All figures in USD
Veracyte, Inc. Annual Profit & Loss
All figures in USD
About Veracyte, Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
Veracyte, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $45.62 | $43.21 | -6.39% |
Sep 2026 | $42.85 | $46.16 | +1.94% |
Aug 2026 | $46.36 | $45.28 | -1.84% |
Jul 2026 | $59.48 | $46.13 | -21.42% |
Jun 2026 | $46.25 | $58.70 | +26.63% |
May 2026 | $32.95 | $46.36 | +40.80% |
Apr 2026 | $32.30 | $32.92 | +2.29% |
Mar 2026 | $35.88 | $32.19 | -11.94% |
Feb 2026 | $38.17 | $36.55 | -3.93% |
Jan 2026 | $42.36 | $38.05 | -9.65% |
Dec 2025 | $46.84 | $42.12 | -11.04% |
Nov 2025 | $35.80 | $47.34 | +30.38% |